Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of duloxetine 60 mg to 120 mg once daily in patients with chronic low back pain

Trial Profile

Effect of duloxetine 60 mg to 120 mg once daily in patients with chronic low back pain

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Jul 2012

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Back pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 01 Jun 2010 Results were published in Spine.
    • 13 Nov 2008 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top